Bone response to intermittent parathyroid hormone is altered in mice null for {beta}-Arrestin2 - PubMed (original) (raw)
. 2005 Apr;146(4):1854-62.
doi: 10.1210/en.2004-1282. Epub 2005 Feb 10.
Affiliations
- PMID: 15705780
- DOI: 10.1210/en.2004-1282
Bone response to intermittent parathyroid hormone is altered in mice null for {beta}-Arrestin2
S L Ferrari et al. Endocrinology. 2005 Apr.
Abstract
Intermittent PTH administration increases bone turnover, resulting in net anabolic effects on bone. These effects are primarily mediated by intracellular cAMP signaling. However, the molecular mechanisms that regulate PTH activity in bone remain incompletely understood. beta-Arrestin2, a G protein-coupled receptor regulatory protein, inhibits PTH-stimulated cAMP accumulation in vitro. Using beta-arrestin2(-/-) (KO) and wild-type (WT) mice, we investigated the response to PTH in primary osteoblasts (POB) and the effects of intermittent PTH administration on bone mass and microarchitecture in vivo. Compared with that in WT mice, PTH-stimulated intracellular cAMP was increased and sustained in KO POB. Intermittent exposure of POB to PTH significantly decreased the ratio of osteoprotegerin (OPG) receptor activator of nuclear factor-kappaB ligand (RANKL) mRNA expression in KO POB, whereas it increased this ratio in WT POB. Total body bone mass and cortical and trabecular bone parameters were 5-10% lower in male KO mice compared with WT, and these differences were magnified upon in vivo administration of intermittent PTH (80 mug/kg.d) for 1 month. Thus, PTH significantly increased total body bone mineral content as well as vertebral trabecular bone volume and thickness in WT, but not KO mice. The anabolic response to PTH in cortical bone was also slightly more pronounced in WT than KO mice. Histomorphometry indicated that PTH prominently stimulated indexes of bone formation in both WT and KO mice, whereas it significantly increased indexes of bone resorption (i.e. osteoclast number and surface) in KO mice only. In conclusion, these results suggest that beta-arrestins may specify the activity of intermittent PTH on the skeleton by limiting PTH-induced osteoclastogenesis.
Similar articles
- Anabolic action of parathyroid hormone is skeletal site specific at the tissue and cellular levels in mice.
Iida-Klein A, Zhou H, Lu SS, Levine LR, Ducayen-Knowles M, Dempster DW, Nieves J, Lindsay R. Iida-Klein A, et al. J Bone Miner Res. 2002 May;17(5):808-16. doi: 10.1359/jbmr.2002.17.5.808. J Bone Miner Res. 2002. PMID: 12009011 - beta-Arrestin2 regulates the differential response of cortical and trabecular bone to intermittent PTH in female mice.
Bouxsein ML, Pierroz DD, Glatt V, Goddard DS, Cavat F, Rizzoli R, Ferrari SL. Bouxsein ML, et al. J Bone Miner Res. 2005 Apr;20(4):635-43. doi: 10.1359/JBMR.041204. Epub 2004 Dec 6. J Bone Miner Res. 2005. PMID: 15765183 Free PMC article. - Beta-Arrestin2 regulates RANKL and ephrins gene expression in response to bone remodeling in mice.
Pierroz DD, Rufo A, Bianchi EN, Glatt V, Capulli M, Rucci N, Cavat F, Rizzoli R, Teti A, Bouxsein ML, Ferrari SL. Pierroz DD, et al. J Bone Miner Res. 2009 May;24(5):775-84. doi: 10.1359/jbmr.081237. J Bone Miner Res. 2009. PMID: 19113915 Free PMC article. - [Effects of parathyroid hormone on bone metabolism : differences between intermittent and continuous treatment].
Ishizuya T. Ishizuya T. Clin Calcium. 2012 Mar;22(3):357-63. Clin Calcium. 2012. PMID: 22370302 Review. Japanese. - Parathyroid hormone: anabolic and catabolic actions on the skeleton.
Silva BC, Bilezikian JP. Silva BC, et al. Curr Opin Pharmacol. 2015 Jun;22:41-50. doi: 10.1016/j.coph.2015.03.005. Epub 2015 Apr 5. Curr Opin Pharmacol. 2015. PMID: 25854704 Free PMC article. Review.
Cited by
- Contributions of parathyroid hormone (PTH)/PTH-related peptide receptor signaling pathways to the anabolic effect of PTH on bone.
Yang D, Singh R, Divieti P, Guo J, Bouxsein ML, Bringhurst FR. Yang D, et al. Bone. 2007 Jun;40(6):1453-61. doi: 10.1016/j.bone.2007.02.001. Epub 2007 Feb 16. Bone. 2007. PMID: 17376756 Free PMC article. - Parathyroid hormone induces differentiation of mesenchymal stromal/stem cells by enhancing bone morphogenetic protein signaling.
Yu B, Zhao X, Yang C, Crane J, Xian L, Lu W, Wan M, Cao X. Yu B, et al. J Bone Miner Res. 2012 Sep;27(9):2001-14. doi: 10.1002/jbmr.1663. J Bone Miner Res. 2012. PMID: 22589223 Free PMC article. - 'Biasing' the parathyroid hormone receptor: a novel anabolic approach to increasing bone mass?
Gesty-Palmer D, Luttrell LM. Gesty-Palmer D, et al. Br J Pharmacol. 2011 Sep;164(1):59-67. doi: 10.1111/j.1476-5381.2011.01450.x. Br J Pharmacol. 2011. PMID: 21506957 Free PMC article. Review. - Multiple Transduction Pathways Mediate Thyrotropin Receptor Signaling in Preosteoblast-Like Cells.
Boutin A, Neumann S, Gershengorn MC. Boutin A, et al. Endocrinology. 2016 May;157(5):2173-81. doi: 10.1210/en.2015-2040. Epub 2016 Mar 7. Endocrinology. 2016. PMID: 26950201 Free PMC article. - Regulation of beta catenin signaling and parathyroid hormone anabolic effects in bone by the matricellular protein periostin.
Bonnet N, Conway SJ, Ferrari SL. Bonnet N, et al. Proc Natl Acad Sci U S A. 2012 Sep 11;109(37):15048-53. doi: 10.1073/pnas.1203085109. Epub 2012 Aug 27. Proc Natl Acad Sci U S A. 2012. PMID: 22927401 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials